Antisense oligodeoxynucleotides as specific tools for studying neuroendocrine and behavioral functions: Some prospects and problems

Journal of Neuroscience Methods

Volumn 71, Issue 1, 1997, Pages 45-53

  Nicot, Arnaud ^a   Pfaff, Donald W ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

behavior; central nervous system; gene expression; hormone; neurotransmitter; peptide; phosphorothioate; receptor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; HORMONE; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BEHAVIOR; BRAIN FUNCTION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

EID: 0030960685     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(96)00125-2     Document Type: Article

References (57)

1. Akabayashi, A., Wahlestedt, C., Alexander, J.T. and Leibowitz, S.F. (1994) Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by natisense oligonucleotide suppresses feeding behavior and insulin secretion, Mol. Brain Res., 21: 55-61.
2. Akhtar, S., Kole, R. and Juliano, R.L. (1992) Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera, Life Sci, 49: 1793-1801.
3. Akhtar, S. and Juliano, R.L. (1992) Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell Biol., 2: 139-144.
4. Altscul, S., Gish, W., Miller, W., Myers, E. and Lipman, D. (1990) Basic local alignment search tool, J. Mol. Biol., 215: 403-410.
5. Beltinger, C., Saragovi, H.U., Smith, R.M., LeSauteur, L., Shah., N., DeDionisio, L., Christensen, L, Raible, A., Jarett, L. and Gewirtz, A.M. (1995) Binding, uptake and intracellular trafficking of phosphorothioate-modified oligonucleotides, J. Clin. Invest., 95: 1814-1823.
6. Boiziau, C., Kurfurst, R., Cazenave, C., Roig, V., Thuong, N.T. and Toulme, J.J. (1991) Inhibition of translation initiation by antisense oligonucleotides via a RNAse H independent mechanism, Nucleic Acids Res., 19: 1113-1139.
7. Cha, X.Y., Xu, H., Ni, Q., Partilla, J.S., Rice, K.C., Matecka, D., Calderon, S.N., Porreca, F., Lai, J. and Rothman, R.B. (1995) Opioid peptide receptor studies. 4. Antisense oligodeoxynucleotide to the delta opioid receptor delineates opioid receptor subtypes, Regul. Peptides, 59: 247-254.
8. Chavani, C., Connell, Y. and Neckers, L. (1995) Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers, Mol. Pharmacol., 48: 738-746
9. Chiang, M.Y., Chan, H., Zounes, M.A., Freier, S.M., Lima, W.F. and Bennet, F.C. (1991) Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms, J. Biol. Chem., 266: 18162-18171.
10. Chiasson, B.J., Hooper, M.L., Murphy, P.R. and Robertson, H.A. (1992) Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain, Eur. J. Pharmacol., 227: 451-453.
11. Chiasson, B.J., Armstrong, J.N., Hooper, M.L., Murphy, P.R. and Robertson, H.A. (1994) The application of antisense oligonucleotide technology to the brain: some pitfalls, Cell. Mol. Neurobiol., 14: 507-521.
12. Chikaraishi, D.M., Deb, S.S. and Sueoka, N. (1978) Sequence complexity of nuclear RNAs in adult rat tissues, Cell, 13: 111-120.
13. Chikaraishi, D.M. (1979) Complexity of cytoplasmic polyadenylated and non polyadenylated rat brain ribonucleic acids, Biochemistry, 18: 3249-3256.
14. Dash, P., Lotan, I., Knapp, M., Kandel, E.R. and Goelet, P. (1987) Selective elimination of mRNAs in vivo: complementary oligonucleotides promotes RNA degradation by an RNAse H-like activity, Proc. Natl. Acad. Sci. USA, 84: 7896-7900.
15. Falker, B., Herlitse, S., Amthor, B., Zenner, H.P. and Ruppersberg, J.P. (1994) Short antisense oligonucleotide-mediated inhibition is strongly dependent oligo on length and concentration but almost independent of location of the targeted sequence, J. Biol. Chem., 269: 16187-16194.
16. Felgner, J.H., Kumar, R., Sridhar, C.N., Wheeler, C.J., Tsai, Y.J., Border, R., Ramsey, P., Martin, M. and Felgner, P.L. (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations, J. Biol. Chem., 4: 2550-2561.
17. Furdon, P.J., Dominski, Z. and Kole, R. (1989) RNAse H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds, Nucleic Acids Res., 17: 9193-9204.
18. Georgieva, J., Heilig, M., Nylander, I., Herrera-Marshitz, M. and Terenius, L. (1995) In vivo antisense inhibition of prodynorphin expression in rat striatum: dose-dependence and sequence specificity, Neurosci. Lett., 192: 69-71.
19. Gyurko, R., Wielbo, D. and Phillips, M.I. (1993) antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduced hypertension of neurogenic origin, Regul. Peptides, 49: 167-174.
20. Héléne, C. and Toulme, J.J. (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids, Biochim. Biophys. Acta, 1049: 99-125
21. Kalra, P.S., Bonavera, J.J. and Kalra, S.P. (1995) Central administration of antisense oligodeoxynucleotides to neuropeptideY (NPY) mRNA reveals the critical role of newly synthesized NPY in regulation of LHRH release, Regul. Peptides, 59: 215-220.
22. Landgraf, R., Gerstberger, R., Montkowki, A., Probst, J.C., Wotjak, C.T., Holsboer, F. and Engelmann, M. (1995) VI vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities and anxiety-related behavior in rats, J. Neurosci., 15: 4250-4258.
23. Loke, S.L., Stein, C.A., Zhang, X.H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J.S. and Neckers, L.M. (1989) Characterization of oligonucleotide transport into living cells, Proc. Natl. Acad. Sci. USA, 86: 3474-3478.
24. Mani, S., Blaustein, J.D., Allen, J.M.C., Law, S.W., O'Malley, B.W. and Clark, J.H. (1994) Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor. Endocrinology, 135: 1409-1414.
25. Marcus-Sekura, C.J. (1988) Techniques for using antisense oligonucleotides to study gene expression, Anal. Biochem., 172: 289-295.
26. McCarthy, M.M., Schlenker, E.H. and Pfaff, D.W. (1993a) Enduring consequences of neonatal treatment with antisense oligonucleotides to estrogen receptor messenger ribonucleic acid, Endocrinology, 133: 433-439.
27. McCarthy, M.M., Brooks, P.J., Pfaus, J.G., Brown, H.E., Flanagan, L.M., Schwartz-Giblin, S. and Pfaff, D.W. (1993b) Antisense oligonucleotides in behavior neuroscience, Neuroprotocols: Compan. Methods Neurosci., 2: 67-74.
28. 67 mRNAs modulate reproductive behavior in the female rat, Brain Res., 636: 209-220.
29. McCarthy, M.M., Kleopoulos, S.P., Mobbs, C.V. and Pfaff, D.W. (1994b) Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat, Neuroendocrinology, 59: 432-440.
30. Meeker, R., LeGrand, G., Ramirez, J., Smith, T. and Shih, Y.H. (1995) Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects, J. Neuroendocrinol., 7: 419-428.
31. Morris, M and Lucion, A.B. (1995) Antisense oligonucleotides in the study of neuroendocrine systems, J. Neuroendocrinol., 7: 493-500.
32. Morris, M., Callahan, M.F., Li, P., Lucion, A.B. (1995) Central oxytocin mediates stress-induced tachycardia, J. Neuroendocrinol., 7: 455-459.
33. Moulds, C., Lewis, J.G., Froehler, B.C., Grant, D., Huang, T., Milligan, J.F., Matteucci, M.D. and Wagner, R.W (1995) Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides, Biochemistry, 34: 5044-5053.
34. Neumann, I., Porter, D.W.F., Landgraf, R. and Pittman, Q.J. (1994) Rapid effect on suckling of an oxytocin antisense oligonucleotide administered into rat supraoptic nucleus, Am. J. Physiol., 267: R852-R858.
35. Neumann, I., Kremarik, P. and Pittman, Q.J. (1995) Acute, sequence-specific effects of oxytocin and vasopressin antisense oligonucleotides on neuronal responses, Neuroscience, 69: 997-1003.
36. Ogawa, S., Olazabal, U.E., Parhar, I.S. and Pfaff, D.W. (1994) Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproducitve bahavior and progesterone receptor immunoreactivity, J. Neurosci., 14: 1766-1674.
37. Ogawa, S., Brown, H.E., Okano, H.J. and Pfaff, D.W. (1995) Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain, Regul. Peptides, 59: 143-150.
38. Peyman, A., Ryte, A., Helsberg, M., Kretzschmar, G., Mag, M. and Uhlman, E. (1995) Enhanced cellular uptake of G-rich oligonucleotides, Nucleosides Nucleotides, 14: 3-5.
39. Pollio, G., Xue, P., Zanisi, M., Nicolin, A. and Maggi, A. (1993) Antisense oligonucleotide blocks progesterone-induced lordosis behavior in ovariectomized rats, Mol. Brain Res., 19: 135-139.
40. Sakai, R.R., He, P.F., Yang, X.D., Ma, L.Y., Guo, Y.F., Reilly, J.J., Moga, C.N. and Fluharty, S.J. (1994) Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II, J. Neurochem., 62: 2053-5056.
41. Sainio, K., Saarma, M., Nonclerq, D., Paulin, L., Sariola, H. (1994) Antisense inhibition of low affinity nerve growth factor receptor in kidney cultures: power and pitfalls. Cell. Mol. Neurobiol., 14: 439-457.
42. Skutella, T., Probst, J.C., Engelmann, M., Wotjak, C.T., Landgraf, R. and Jirikowski, G.F. (1994a) Vasopressin antisense oligonucleotide induces temporary diabetes insidipus in rat, J. Neuroendocrinol., 6; 121-125.
43. Skutella, T., Criwell, H., Moy, S., Probst, J.C., Breese, G.R., Jirikowski, G.F and Holsboer, F. (1994b) Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat, J. Neuroendocrinol., 6: 121-125.
44. Spampinato, S., Canossa, M., Carboni, L., Campana, G., Leanza, G. and Ferri, S. (1994) Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to β-endorphin mRNA, Proc. Natl. Acad. Sci. USA, 91: 8072-8076.
45. Standifer, K.M., Chien, C.C., Wahlestedt, C., Brown, G.P. and Pasternak, G.W. (1994) Selective loss of - opioid analgesia and binding by antisense oligonucleotides to a - opioid receptor, Neuron, 12: 805-810.
46. Standifer, K.M., Jenab, S., Su, W., Chien, C.C., Pan, Y.X., Inturrisi C.E. and Pasternak, G.W. (1995) Antisense oligodeoxynucleotides to the clones - receptor DOR-1: uptake, stability and regulation of gene expression, J. Neurochem., 65: 1981-1987.
47. Stein, C.A., Mori, K., Loke, S.L., Subasinghe, C., Shinozuka, K., Cohen, J.S. and Neckers, L.M. (1988) Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: characterization and preliminary kinetics of cellular uptake, Gene, 72: 333-341.
48. Szklarczyk, A. and Kaczmarek, L. (1995) Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain, J. Neurosci. Methods, 60: 181-187.
49. Wagner, R.W., Matteucci, M.D., Lewis, J.G., Guttierrez, A.J., Moulds, C. and Froehler, B, C (1993) Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidine. Science, 260: 1510-1513.
50. Wahlestedt, C., Pich, E.M., Koob, G.F., Yee, F. and Heilig, M. (1993a) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides, Science, 259: 528-531.
51. Wahlestedt, C., Golanov, E., Yamamoto, S., Yee, F., Ericson, H., Yoo, H., Inturrisi, C.E. and Reis, D.J. (1993b) Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarction, Nature, 363: 260-263.
52. Wahlestedt, C. (1994) Antisense oligonucleotides strategies in neuropharmacology, Trends Pharmacol. Sci., 15: 42-46.
53. Walder, R.Y. and Walder, J.A. (1988) Role of RNAse H in hybrid-arrested translation by antisense oligonucleotides, Proc. Natl. Acad. Sci. USA, 85: 5011-5015.
54. Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J.R., Neckers, L.M. (1993) Stability; clearance and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application with the central nervous system, Proc. Natl. Acad. Sci. USA, 90: 4665-4669.
55. Woolf, T.M., Melton, D.A. and Jennings, C.G.B. (1992) Specificity of antisense in vivo, Proc. Natl. Acad. Sci. USA, 89: 7305-7309.
56. Zhou, L.W., Zhang, S.P., Qin, Z.H. and Weiss, B. (1994) In vivo administration of an oligonucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum, J. Pharmacol. Exp. Ther., 268: 1015-1023.
57. Yakubov, L.A., Deeva, E.A., Zarytova, V.F., Ivanova, E.M., Ryte, A.S., Yurchenko, L.V. and Vlassov, V.V. (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. USA, 86: 6454-6458.